NEOLISE BPC-157 /TB-500 Recovery Reviews and Complaints 2026: Peptide Supplement
NEOLISE Recovery is a peptide supplement product marketed as containing BPC-157 and TB-500, two compounds promoted for muscle recovery, joint repair, and physical rehabilitation. The product is distributed through the MaxBounty CPA network with a $300 per lead payout, and is targeted at active adults, athletes, fitness enthusiasts, and biohackers aged 25–55. Notably, the offer explicitly prohibits fake news layouts, fabricated endorsements, before-and-after imagery, and any claim of guaranteed outcomes — restrictions that suggest awareness of prior compliance issues in this marketing vertical.
However, there is a critical distinction that must be made up front: NEOLISE Recovery is a compounded peptide product, not an FDA-approved medication. BPC-157 and TB-500 are not approved for human use in the United States, have no published Phase 1 human safety data, and lack controlled human efficacy trials. The FDA has noted that it has not identified any safety information for the proposed routes of administration, which include subcutaneous injection. Both peptides are banned by the World Anti-Doping Agency.
Review Summary Box
| Feature | Details |
|---|---|
| Overall Rating | 2.0 / 5 ⭐ |
| Best For | No reliable recommendation — significant safety and regulatory concerns |
| Product Type | Compounded peptide supplement (BPC-157 + TB-500) |
| Active Ingredients | BPC-157 (Body Protection Compound-157), TB-500 (Thymosin Beta-4 fragment) |
| Format | Not fully disclosed (likely injectable or oral, based on peptide category) |
| Price | Not publicly disclosed |
| Money-Back Guarantee | Not disclosed |
| Regulatory Status | Not FDA-approved for human use |
| WADA Status | Banned — both peptides are prohibited at all times |
| Distribution | MaxBounty CPA network; $300 per lead payout |
| Target Audience | Athletes, biohackers, fitness enthusiasts aged 25–55 |
| Restrictions on Affiliates | No fake news, no fabricated endorsements, no guaranteed outcomes |
What Is NEOLISE Recovery?
NEOLISE Recovery is marketed as a premium peptide supplement containing BPC-157 and TB-500, two compounds that have become increasingly popular in the “wellness peptide” space despite lacking FDA approval for human use. The product is positioned for recovery from injury, joint health, and advanced physical rehabilitation.
The BPC-157 and TB-500 Combination
The combination of BPC-157 and TB-500 is often referred to in fitness communities as the “Wolverine stack” because of its purported synergistic effects on tissue repair. BPC-157 is derived from a protein found in human gastric juice, while TB-500 is a fragment of thymosin beta-4.
According to a 2026 review in JAAOS Global Research & Reviews, wound-healing peptides such as BPC-157 and TB-500 “promote angiogenesis, integrin-mediated extracellular matrix remodeling, and fibroblast activation”. However, this research is largely preclinical — the vast majority of studies have been conducted in animal models, not humans.
The Marketing Context
NEOLISE Recovery is distributed through the MaxBounty affiliate network, a performance-based CPA platform. The offer pays $300 per qualified lead, with conversions only counted after payment is received, provider approval is granted, the 48-hour cancellation window has passed, and the medication has shipped. This multi-step approval process and high payout are typical of high-ticket telehealth or compounded medication offers.
The offer restrictions are notable: affiliates are prohibited from using “fake news layouts or fabricated endorsements, before and after imagery, any claim of guaranteed outcomes, and any depiction of a provider or clinician who isn’t real”. These restrictions were likely imposed because this marketing vertical has a history of deceptive practices.
The Critical Safety Problem: No Human Safety Data
The most important fact about NEOLISE Recovery is not about the specific product — it is about the ingredients themselves. BPC-157 and TB-500 have not been approved for human use, and there is a profound lack of human safety and efficacy data.
What the Regulatory and Medical Authorities Say
| Source | Finding |
|---|---|
| ECRI / ISMP (2026) | “Many compounded peptides, including BPC-157, TB-500… are not approved for human use” with “no published Phase 1 human safety data and no controlled human efficacy trials” |
| FDA | “We found no human pharmacokinetic data for BPC-157 after oral, SC, nasal, or transdermal administration” |
| FDA (2026) | “The agency has not identified any safety information ‘for the proposed routes of administration,’ which include a subcutaneous injection” |
| Medical literature | “BPC-157 and TB-500, despite extensive preclinical data, lack adequate human clinical trials and long-term safety data” |
| WADA | Both peptides are banned — prohibited at all times for athletes |
Reported Adverse Events
A 2026 FDA report documented a 40-year-old female who developed diffuse hyperpigmentation and gingival darkening after using a product containing BPC-157 and TB-500 subcutaneously twice daily for “joint healing” for one week. The product was labeled “for research purposes only” — a common disclaimer used by gray-market peptide sellers to avoid regulatory scrutiny.
A 2026 white paper from ECRI and ISMP cited reported adverse events including cardiac events, renal dysfunction, melanoma, and infections. The same white paper noted “a halted clinical trial following a fatal cardiac event” involving a related peptide.
The “Research Purposes Only” Loophole
Many BPC-157 and TB-500 products are sold with a “for research purposes only” label, which is intended to bypass FDA regulation of drugs. However, this label does not mean the product is safe or legal for human consumption. As one FDA report noted, the patient who developed hyperpigmentation used a product “labeled for ‘research purposes only’ from Cellular Peptide LLC”.
What the Research Actually Shows
BPC-157
BPC-157 has been studied extensively in animal models, with research suggesting potential benefits for tendon healing, ligament repair, gut protection, and inflammation reduction. However, human clinical trials are extremely limited. As the JAAOS review noted, therapeutic peptides in orthopaedics are “largely limited to animal studies, with little” human data.
TB-500
TB-500 is a synthetic version of thymosin beta-4, a protein involved in cell migration, blood vessel formation, and tissue repair. Like BPC-157, the evidence for TB-500 in humans is almost entirely preclinical. The FDA has identified no human exposure data for TB-500.
The Combination
There is no clinical evidence that BPC-157 and TB-500 work synergistically in humans. The “Wolverine stack” concept is based on anecdotal reports and animal research, not controlled human trials.
Website and Marketing Concerns
The $300 Per Lead Payout
The $300 per lead payout on MaxBounty is a significant red flag. This is among the highest payouts in the nutra/health vertical, and it means affiliates have a strong financial incentive to promote the product aggressively. High payouts often correlate with high-margin products that may not deliver on their promises.
The Restrictions Tell a Story
The fact that the offer explicitly prohibits fake news layouts, fabricated endorsements, before-and-after imagery, and guaranteed outcomes suggests that these tactics were being used by affiliates in this vertical. While the restrictions themselves are positive, their existence indicates that this category has a history of deceptive marketing.
No Independent Reviews
A search for independent reviews of NEOLISE Recovery returns no results on Trustpilot, Reddit, or other consumer review platforms. There is no verifiable customer feedback to assess whether the product is effective, whether it ships, or whether refunds are honored.
The only Trustpilot result for a similarly named entity — “Neliese” — shows a 2.5/5 rating with complaints about unauthorized subscription charges: “Scammers, be aware. They took money from my account without any knowledge. I was contacted by my bank and fraud team regarding these transactions. Apparently, there was a subscription for £49.50 in place”. It is unclear whether this is related to NEOLISE Recovery, but the similarity in name and the nature of the complaint are concerning.
Safety and Regulatory Considerations
Not FDA-Approved
BPC-157 and TB-500 are not approved by the FDA for any human indication. They are not dietary supplements, and they are not compounded medications that fall within standard pharmacy practice. They exist in a regulatory gray zone that allows sellers to market them as “research chemicals” while consumers use them off-label.
Banned by WADA
Both peptides are prohibited at all times by the World Anti-Doping Agency. Any athlete subject to drug testing who uses NEOLISE Recovery would face a doping violation.
Unknown Long-Term Safety
The long-term safety profile of BPC-157 and TB-500 in humans is completely unknown. There are no long-term studies, no Phase 1 safety data, and no post-market surveillance. The reported adverse events — cardiac events, renal dysfunction, melanoma, infections, and hyperpigmentation — are serious and warrant caution.
Who Should Avoid
- Athletes subject to drug testing — both peptides are WADA-banned
- Anyone with cardiovascular conditions — cardiac events have been reported
- Anyone with a history of cancer — melanoma has been reported
- Pregnant or nursing women — safety not established
- Anyone taking prescription medications — no interaction data exists
- Anyone who wants FDA-approved, clinically tested products — these peptides do not qualify
Pricing and Where to Buy
Pricing information for NEOLISE Recovery is not publicly disclosed. The product is sold through affiliate marketing channels, and the offer details do not include consumer pricing. The MaxBounty offer page lists a payout of $300 per lead but does not disclose the retail price.
Critical Warning: Because this product is distributed through CPA affiliate networks with high payouts, consumers should exercise extreme caution. High-payout offers are often associated with aggressive marketing, and the lack of independent reviews means there is no way to verify the product’s quality, safety, or whether refunds are honored.
Final Verdict
Strengths
- None supported by human clinical evidence. The product contains peptides that have not been approved for human use and lack basic safety data. There are no independent reviews, no published human trials, and no verifiable customer feedback.
Weaknesses
- ⚠️ Not FDA-approved — BPC-157 and TB-500 are not approved for human use
- ⚠️ No human safety data — no Phase 1 trials, no controlled efficacy studies
- ⚠️ No human pharmacokinetic data — the FDA found none for BPC-157
- ⚠️ Banned by WADA — prohibited for athletes
- ⚠️ Reported adverse events — cardiac events, renal dysfunction, melanoma, infections, hyperpigmentation
- ⚠️ $300 per lead payout — high affiliate incentive for aggressive marketing
- ⚠️ No independent reviews — no Trustpilot, Reddit, or consumer feedback
- ⚠️ “Research purposes only” loophole — common gray-market tactic to avoid regulation
- ⚠️ No disclosed pricing or refund policy
Who May Benefit
Based on the available evidence, no one should use this product without a physician’s supervision and a clear understanding of the risks. The peptides are not approved for human use, have no established safety profile, and carry reported serious adverse events.
Who Should Avoid
Everyone. The combination of unapproved peptides, absent human safety data, WADA prohibition, reported serious adverse events, and high-pressure affiliate marketing makes this a high-risk product. If you are experiencing joint pain or injury recovery needs, consult a physician about evidence-based treatments rather than using unapproved peptides.
Overall Recommendation
Rating: 2.0 out of 5 Stars
NEOLISE Recovery contains BPC-157 and TB-500, two peptides that are not FDA-approved for human use and have no published human safety or efficacy data. The FDA has found no human pharmacokinetic data for BPC-157, no human exposure data for TB-500, and has not identified safety information for the proposed routes of administration. Both peptides are banned by WADA, and reported adverse events include cardiac events, renal dysfunction, melanoma, infections, and hyperpigmentation. The product is distributed through a CPA affiliate network with a $300 per lead payout and has no independent reviews. For anyone considering peptide therapy, the safer path is to consult a physician about FDA-approved treatments with established safety profiles.
Frequently Asked Questions
What is NEOLISE Recovery?
NEOLISE Recovery is a peptide supplement product marketed as containing BPC-157 and TB-500, two compounds promoted for muscle recovery and joint repair. It is distributed through the MaxBounty CPA affiliate network.
Are BPC-157 and TB-500 FDA-approved?
No. Neither BPC-157 nor TB-500 is approved by the FDA for human use. They exist in a regulatory gray zone and are often sold as “research chemicals”.
Is NEOLISE Recovery safe?
There is no human safety data for BPC-157 or TB-500. The FDA has found no human pharmacokinetic data for BPC-157 and no human exposure data for TB-500. Reported adverse events include cardiac events, renal dysfunction, melanoma, infections, and hyperpigmentation.
Why is BPC-157 banned by WADA?
The World Anti-Doping Agency bans BPC-157 and TB-500 because of the lack of safety data and potential for abuse. They are prohibited at all times for athletes.
Can I buy NEOLISE Recovery?
NEOLISE Recovery is distributed through affiliate marketing channels. Pricing and availability are not publicly disclosed. Given the significant safety and regulatory concerns, purchase is not recommended.
What should I do instead?
If you are dealing with joint pain, injury recovery, or tissue repair needs, consult a physician about FDA-approved treatments with established safety profiles. There are evidence-based options for musculoskeletal recovery that do not involve unapproved peptides.
Is NEOLISE Recovery the same as Neliese?
Unclear. A Trustpilot page for “Neliese” shows a 2.5/5 rating with complaints about unauthorized subscription charges. It is not confirmed whether this is related to NEOLISE Recovery, but the name similarity and complaint pattern are worth noting.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. BPC-157 and TB-500 are not FDA-approved for human use and are banned by WADA. Always consult a qualified healthcare professional before starting any new supplement or treatment, especially if you have existing health conditions, take medications, or are pregnant or nursing. Individual results may vary.
Read also
Care Bare Rx Reviews 2026: GLP-1 Telehealth Pros, Cons & Pricing
